Log in

Correlation Between Serum 1,25(OH)2D3, Serum Phosphorus, and Parathyroid Hormone and Parathyroid Function After Central Lymph Node Dissection in Patients with Papillary Thyroid Carcinoma

  • Original Paper
  • Published:
Molecular Biotechnology Aims and scope Submit manuscript

Abstract

This work was to demonstrate the relationship between serum 1,25-dihydroxyvitamin D3 (1,25(OH)2D3), serum phosphorus (SP), and parathyroid hormone (PTH) and parathyroid function after central lymph node dissection (CLND) in patients with papillary thyroid carcinoma (PTC). 200 PTC patients after CLND were included, who were rolled into a control group (CG) (n = 89 cases without hypoparathyroidism) and an observation group (OG) (n = 111 cases with complicated hypoparathyroidism). The 1,25(OH)2D3, SP, and PTH levels were detected, and the diagnostic effect of these indicators was assessed. The serum PTH levels of patients in CG after surgery were normal relative to those before surgery, while the serum PTH of patients in OG was relatively lower. 1,25(OH)2D3 concentration of patients in OG was also inferior to CG, while the SP level was superior (P < 0.05). Hypoparathyroidism was positively correlated with serum PTH (r = 0.382) and 1,25(OH)2D3 (r = 0.321) and negatively correlated with SP (r =  − 0.211). The area under the curve (AUC) (0.893), sensitivity (90.83%), and specificity (94.77%) of the joint diagnosis of 1,25(OH)2D3 + SP + PTH were greatly superior to those of the single diagnosis and the pairwise diagnosis with the three indicators (P < 0.05). Hypoparathyroidism in patients with PTC after CLND surgery was positively correlated with 1,25(OH)2D3 and PTH and negatively correlated with SP concentration. In addition, the combination diagnosis of 1,25(OH)2D3, PTH, and SP worked well.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

Data Availability

All data generated or analysed during this study are included in this published article.

References

  1. Cauteruccio, M., Perna, A., Vitiello, R., Oliva, M. S., Pesare, E., Ziranu, A., & Merendi, G. (2020). A rare case of post-traumatic infected pilomatricoma of the finger of the hand diagnosed after performing radioiodine therapy. Journal of Biological Regulators and Homeostatic Agents, 34(3 Suppl. 2), 83–87.

    CAS  PubMed  Google Scholar 

  2. Huang, X. C., Li, H. S., Hu, X. H., & Yi, T. H. (2020). Efficacy of carbon nanoparticles for parathyroid glands protection during total thyroidectomy and bilateral central lymph nodes dissection for thyroid cancer: A systematic review and meta-analysis. Acta Medica Mediterr, 38, 745–751.

    Google Scholar 

  3. M A. E. (2021). Preoperative thyroid-stimulating hormone associated risk of differentiated thyroid cancer in patients with thyroid nodules. Cellular and Molecular Biology (Noisy-le-Grand, France), 67(3), 85–91.

  4. Kotanidou, E. P., Giza, S., Tsinopoulou, V. R., Margaritis, K., Papadopoulou, A., Sakellari, E., Kolanis, S., Litou, E., Serbis, A., & Galli-Tsinopoulou, A. (2023). The prognostic significance of BRAF gene analysis in children and adolescents with papillary thyroid carcinoma: A systematic review and meta-analysis. Diagnostics (Basel, Switzerland), 13(6), 1187.

    CAS  PubMed  Google Scholar 

  5. Stergioula, A., Pantelis, E., Kormas, T., & Agrogiannis, G. (2023). Case report: Skeletal muscle metastasis from follicular thyroid carcinoma presenting as synovial sarcoma. Frontiers in Oncology, 13, 994729.

    Article  PubMed  PubMed Central  Google Scholar 

  6. Paspala, A., Papakonstantinou, D., Pikoulis, E., Tomos, P., & Nastos, C. (2022). Synchronous sternal metastasectomy and total thyroidectomy for differentiated thyroid cancer: A rare case report. Cureus, 14(11), e31294.

    PubMed  PubMed Central  Google Scholar 

  7. Spaziani, E., Di Filippo, A. R., Di Cristofano, C., Caruso, G., Spaziani, M., Orelli, S., Fiorini, F., Picchio, M., & De Cesare, A. (2021). Incidental parathyroidectomy during total thyroidectomy as a possible risk factor of hypocalcemia. Experience of a single center and review of literature. Acta endocrinologica (Bucharest, Romania: 2005), 17(2), 207–211.

  8. Kaul, P., Kaul, P., Poonia, D. R., Jakhetiya, A., Arora, V., & Garg, P. K. (2021). Risk Benefit analysis of routine thymectomy for differentiated thyroid cancers: A systematic review. Surgery journal (New York, N.Y.), 7(4), e307–e313.

    PubMed  Google Scholar 

  9. Obongo Anga, R., Abbaci, M., Guerlain, J., Breuskin, I., Casiraghi, O., Marhic, A., Benmoussa-Rebibo, N., de Kermadec, H., Moya-Plana, A., Temam, S., Gorphe, P., & Hartl, D. M. (2023). Intraoperative autofluorescence imaging for parathyroid gland identification during total laryngectomy with thyroidectomy. Cancers, 15(3), 875.

    Article  PubMed  PubMed Central  Google Scholar 

  10. Liu, X., Wong, C. K. H., Chan, W. W. L., Au, I. C. H., Tang, E. H. M., & Lang, B. H. H. (2022). Survival after hemithyroidectomy versus total thyroidectomy in non-high-risk differentiated thyroid cancer: Population-based analysis. BJS open, 6(6), zrac146.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Goodman, W. G., Ward, D. T., Martin, K. J., Drayer, D., Moore, C., Xu, J., Lai, J., Chon, Y., & Nemeth, E. F. (2022). Activation of the calcium receptor by calcimimetic agents is preserved despite modest attenuating effects of hyperphosphatemia. Journal of the American Society of Nephrology: JASN, 33(1), 201–212.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Zou, Y., Zhang, N., Tang, Y., Zhan, Z., Yang, M., Lu, Y., Li, G. S., & Zhang, L. (2021). Predictive markers for severe hypocalcemia in dialysis patients with secondary hyperparathyroidism after near-total parathyroidectomy. Annals of Palliative Medicine, 10(10), 10712–10719.

    Article  PubMed  Google Scholar 

  13. Delanaye, P., Lanot, A., Bouquegneau, A., Warling, X., Radermacher, L., Masset, C., Krzesinski, J. M., Moranne, O., & Cavalier, E. (2023). Monitoring 25-OH and 1,25-OH vitamin D levels in hemodialysis patients after starting therapy: Does it make sense? Clinica chimica acta; International Journal of Clinical Chemistry, 539, 50–54.

  14. García Pascual, L., García González, L., Lao Luque, X., Palomino Meneses, L., & Viscasillas Pallàs, G. (2023). Evaluation of an early detection protocol, intensive treatment and control of post-surgical hypoparathyroidism in the first month after total thyroidectomy. Endocrinologia, diabetes y nutricion, 70(3), 202–211.

    Article  PubMed  Google Scholar 

  15. Song, J. L., Li, L. R., Xu, Z. L., Li, J. J., Sun, S. R., & Chen, C. (2022). Long-term survival in patients with papillary thyroid cancer who did not undergo prophylactic central lymph node dissection: A SEER-based study. World Journal of Oncology, 13(3), 136–144.

    Article  PubMed  PubMed Central  Google Scholar 

  16. Chen, Y., Chen, S., Lin, X., Huang, X., Yu, X., & Chen, J. (2021). Clinical analysis of cervical lymph node metastasis risk factors and the feasibility of prophylactic central lymph node dissection in papillary thyroid carcinoma. International Journal of Endocrinology, 2021, 6635686.

    Article  PubMed  PubMed Central  Google Scholar 

  17. Lin, H. Y., Tang, H. Y., Davis, F. B., Mousa, S. A., Incerpi, S., Luidens, M. K., Meng, R., & Davis, P. J. (2012). Nongenomic regulation by thyroid hormone of plasma membrane ion and small molecule pumps. Discovery medicine, 14(76), 199–206.

    PubMed  Google Scholar 

  18. Sciacchitano, S., De Francesco, G. P., Piane, M., Savio, C., De Vitis, C., Petrucci, S., Salvati, V., Goldoni, M., Fabiani, M., Mesoraca, A., Micolonghi, C., Torres, B., Piccinetti, A., Pippi, R., & Mancini, R. (2022). Complete pseudo-anodontia in an adult woman with pseudo-hypoparathyroidism type 1a: A new additional nonclassical feature? Diagnostics (Basel, Switzerland), 12(12), 2997.

    PubMed  Google Scholar 

  19. Baud, G., Jannin, A., Marciniak, C., Chevalier, B., Do Cao, C., Leteurtre, E., Beron, A., Lion, G., Boury, S., Aubert, S., Bouchindhomme, B., Vantyghem, M. C., Caiazzo, R., & Pattou, F. (2022). Impact of lymph node dissection on postoperative complications of total thyroidectomy in patients with thyroid carcinoma. Cancers, 14(21), 5462.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  20. Godlewska, P., Benke, M., Stachlewska-Nasfeter, E., Gałczyński, J., Puła, B., & Dedecjus, M. (2020). Risk factors of permanent hypoparathyroidism after total thyroidectomy and central neck dissection for papillary thyroid cancer: A prospective study. Endokrynologia Polska, 71(2), 126–133.

    Article  CAS  PubMed  Google Scholar 

  21. Dawale, K., & Agrawal, A. (2022). Parathyroid hormone secretion and related syndromes. Cureus, 14(10), e30251.

    PubMed  PubMed Central  Google Scholar 

  22. Zhukov, A., Povaliaeva, A., Abilov, Z., Kovaleva, E., Usoltseva, L., Eremkina, A., Ioutsi, V., Dzeranova, L., Pigarova, E., Rozhinskaya, L., & Mokrysheva, N. (2022). Parameters of vitamin D metabolism in patients with hypoparathyroidism. Metabolites, 12(12), 1279.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  23. **ang, Z., Wang, M., Miao, C., **, D., & Wang, H. (2022). Mechanism of calcitriol regulating parathyroid cells in secondary hyperparathyroidism. Frontiers in Pharmacology, 13, 1020858.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Chindris, A. M., Desai, K., Ozgursoy, S. K., Heckman, M. G., & Casler, J. D. (2023). A parathyroid hormone-guided calcium and calcitriol supplementation protocol reduces hypocalcemia-related readmissions following total thyroidectomy. Endocrine practice: Official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 29(4), 260–265.

    Article  PubMed  Google Scholar 

  25. Antoun, J., Williamson, D., Hubler, M., & Shoemaker, A. H. (2021). Calcitriol and Levothyroxine Dosing for Patients With Pseudohypoparathyroidism. Journal of the Endocrine Society, 5(12), bvab161.

    Article  PubMed  PubMed Central  Google Scholar 

  26. Yao, L., Li, J., Li, M., Lin, C., Hui, X., Tamilselvan, D., Kandi, M., Sreekanta, A., Makhdami, N., Ali, D. S., Dandurand, K., Yang, K., Bilezikian, J. P., Brandi, M. L., Clarke, B. L., Mannstadt, M., Rejnmark, L., Khan, A. A., & Guyatt, G. (2022). Parathyroid hormone therapy for managing chronic hypoparathyroidism: A systematic review and meta-analysis. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 37(12), 2654–2662.

    Article  CAS  PubMed  Google Scholar 

  27. Van Uum, S., Shrayyef, M., M’Hiri, I., Dandurand, K., Ali, D. S., Bilezikian, J. P., Collins, M. T., Mannstadt, M., Rubin, M. R., Siggelkow, H., Tabacco, G., Tay, Y. D., Vokes, T., Winer, K. K., Yao, L., Guyatt, G., Rejnmark, L., & Khan, A. A. (2022). Initial assessment and monitoring of patients with chronic hypoparathyroidism: A systematic current practice survey. Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research, 37(12), 2630–2641.

    PubMed  Google Scholar 

Download references

Acknowledgements

Not applicable.

Funding

The research is supported by: Hongmei Yu, Zhejiang Medical and Health Technology Project, Diagnosis of parathyroid function after central lymph node dissection and neck lymph node dissection using 1,25- (OH) 2-D3 combined with blood calcium and parathyroid hormone, respectively, (No.: 2023XY192). Weiwei Su, Zhejiang Medical and Health Technology Project, Thyroid surgery through the anterior margin of the lateral cervical sternocleidomastoid muscle approach, (No. 2023XY187).

Author information

Authors and Affiliations

Authors

Contributions

HY, HL, WS, ZX, MX, CH and XL analyzed data and writing, participated in collection of data and experimental operations, participated in design testing and supervision testing. All authors read and approve the manuscript version final.

Corresponding author

Correspondence to ** Li.

Ethics declarations

Ethics Approval and Consent to Participate

The study was approved by the local ethics committee of the Tongxiang First People’s Hospital. All experiments were performed in accordance with relevant guidelines and regulations such as the Declaration of Helsinki and the patients signed the informed consent form and agreed to be published.

Consent for Publication

Not applicable.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (DOCX 19 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yu, H., Li, H., Su, W. et al. Correlation Between Serum 1,25(OH)2D3, Serum Phosphorus, and Parathyroid Hormone and Parathyroid Function After Central Lymph Node Dissection in Patients with Papillary Thyroid Carcinoma. Mol Biotechnol (2024). https://doi.org/10.1007/s12033-024-01147-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s12033-024-01147-0

Keywords

Navigation